Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant (2022)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; ROSSI, GIORDANO NOVAK - FMRP ; GUERRA, LORENA TERENE LOPES - FMRP
- Unidade: FMRP
- DOI: 10.3390/biom12111618
- Subjects: ALCALOIDES; ANTIDEPRESSIVOS; ALUCINOGÊNICOS; PLANTAS ALUCINÓGENAS
- Keywords: Ayahuasca; Antidepressant; Psychedelic
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Biomolecules
- ISSN: 2218-273X
- Volume/Número/Paginação/Ano: v. 12, n. 11, art. 1618, p. 1-24, 2022
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
ROSSI, Giordano Novak et al. Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant. Biomolecules, v. 12, n. 11, p. 1-24, 2022Tradução . . Disponível em: https://doi.org/10.3390/biom12111618. Acesso em: 01 abr. 2026. -
APA
Rossi, G. N., Guerra, L. T. L., Baker, G. B., Dursun, S. M., Saiz, J. C. B., Hallak, J. E. C., & Santos, R. G. dos. (2022). Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant. Biomolecules, 12( 11), 1-24. doi:10.3390/biom12111618 -
NLM
Rossi GN, Guerra LTL, Baker GB, Dursun SM, Saiz JCB, Hallak JEC, Santos RG dos. Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant [Internet]. Biomolecules. 2022 ; 12( 11): 1-24.[citado 2026 abr. 01 ] Available from: https://doi.org/10.3390/biom12111618 -
Vancouver
Rossi GN, Guerra LTL, Baker GB, Dursun SM, Saiz JCB, Hallak JEC, Santos RG dos. Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant [Internet]. Biomolecules. 2022 ; 12( 11): 1-24.[citado 2026 abr. 01 ] Available from: https://doi.org/10.3390/biom12111618 - Ayahuasca, pain, and inflammation: a systematic review of preclinical studies
- Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: a mechanistic overview
- The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials
- Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
- Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach
- Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: a transcultural study
- The use of classic hallucinogens/psychedelics in a therapeutic context: healthcare policy opportunities and challenges
- Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic
- Tripping to cope: coping strategies and use of hallucinogens during the COVID-19 pandemic in three cultural contexts
- Psychedelic medicines in major depression: progress and future challenges
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003114461.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
